Breast cancer drug shows promise in treating young infants with PIK3CA-related overgrowth spectrum

By | January 26, 2022
PIK3CA-related overgrowth spectrum (PROS) is a group of rare, incurable disorders caused by mutations in the PIK3CA gene that result in the malformation and overgrowth of various parts of the body.